EVER
EverQuote Inc - Ordinary Shares - Class A

1,541
Loading...
Loading...
News
all
press releases
ORI Outperforms Industry, Hits 52-Week High: How to Play the Stock
Old Republic International gains from solid market presence, low property catastrophe exposure in its General Insurance segment and strong capital position.
Zacks·6h ago
News Placeholder
More News
News Placeholder
Can Principal Financial Balance Growth With Margin Pressures?
PFG benefits from retirement leadership, fee-based income, and consistent shareholder returns despite margin pressures.
Zacks·4d ago
News Placeholder
Root vs. EverQuote: Which Stock Is the Stronger Bet in Insurtech?
EverQuote's debt-free growth strategy and AI-powered platform position it well compared to Root in the insurtech race.
Zacks·17d ago
News Placeholder
Everest Group Is Trading at a Discount: Time to Load Up or Hold Off?
EG expands globally, strengthens its balance sheet, and grows steadily, though ROE still trails industry peers.
Zacks·18d ago
News Placeholder
EVER Rallies 16.3% YTD, Trades at Premium: Should You Buy the Stock?
EverQuote leans on AI, data and a stronger auto focus to drive growth, but faces rising costs, stiff competition and regulatory risks.
Zacks·25d ago
News Placeholder
EverQuote (EVER) Down 2.1% Since Last Earnings Report: Can It Rebound?
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·1mo ago
News Placeholder
ROOT Loses 33% in 3 Months, Trades at a Premium: How to Play the Stock
ROOT shares are down 33% in three months, yet the insurer boasts strong profitability, tech-driven growth and analyst optimism.
Zacks·1mo ago
News Placeholder
Do Options Traders Know Something About EverQuote Stock We Don't?
Investors need to pay close attention to EverQuote stock based on the movements in the options market lately.
Zacks·2mo ago
News Placeholder
Everest Group Trades Below 50-Day SMA: How to Play the Stock?
EG gains from global growth, portfolio strength and a solid balance sheet, but faces weak ROE and catastrophe exposure.
Zacks·2mo ago
News Placeholder
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
EVER trades above its 200-day SMA with strong returns and rising quote requests, though challenges remain ahead.
Zacks·2mo ago

Latest EVER News

View

Advertisement|Remove ads.

Advertisement|Remove ads.